Rosiglitazone increases testosterone in hypogonadal type 2 diabetic men

1. Kapoor D , Channer KS , Jones TH. Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetes. Diabetes Vasc Dis Res 2008;5:135–7;doi:10.3132/dvdr.2008.022.

2. Cohen PG. Aromatase, adiposity, aging and disease. The hypogonadal-metabolic-atherogenic-disease and aging connection. Med Hypotheses 2001;56:702–08.

3. Rubin GL , Ying Z , Lalus AM , Simpson SE. Peroxisome proliferator-activated receptor gamma ligands inhibit biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy. Cancer Res 2000;60:1604–08.

4. Berger J , Tanen M , Elbrecht A et al. Peroxisome proliferator-activated receptor gamma ligands inhibit adipocyte 11beta-hydroxysteroid dehydrogenase type 1 expression and activity. J Biol Chem 2001;276:12629–35.